Metrics Contract Services takes different approaches to First-in-Human studies depending on the desired result:

• Active Pharmaceutical Ingredient (API)-in-Capsules – Using our Xcelodose®600S encapsulator, we can fill API directly into a capsule with high precision and accuracy over a dosage range of 1 mg to 250 mg.
• Blend and Fill – Based on the physical and chemical properties of your product, Metrics has the ability to develop a basic blend of ingredients to help with manual or semi-automated capsule filling.
• Tablets – We may suggest a tablet formulation as the best approach to developing a Phase I dosage form.

We are well-versed in handling highly potent compounds, using hard-wall isolation technology for batch sizes up to and engineered solutions for larger batches. We house manual or automated bottle packaging lines to support your clinical trial preparations.